New horizons in NSCLC targeted therapy: advancements and challenges
FAYETTEVILLE, GA, UNITED STATES, December 16, 2025 /EINPresswire.com/ -- Recent advances in the treatment of non-small cell lung cancer (NSCLC) have led to improved patient outcomes, particularly for those with actionable gene mutations. Tyrosine …